Home » QRxPharma Announces Strategic Collaboration With Paladin Labs
QRxPharma Announces Strategic Collaboration With Paladin Labs
QRxPharma announced execution of a licensing agreement with Paladin Labs for the Canadian commercialization rights to MOXDUO, a patented, immediate release formulation of morphine and oxycodone.
The Herald
The Herald
Upcoming Events
-
07May
-
14May
-
30May